Skip to main content
SpringerLink
Log in

Health Canada is reviewing the heart-related safety of citalopram

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Citalopram: Health Canada reviewing dose-related heart risk. Media Release: 13 Oct 2011. Available from: URL: http://www.hc-sg.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Health Canada is reviewing the heart-related safety of citalopram. React. Wkly. 1376, 2 (2011). https://doi.org/10.2165/00128415-201113760-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113760-00004

Keywords

Search

Navigation